Appointment booking for Dr. Alphonse Pecoraro, MD is currently not available.Dr. Alphonse Pecoraro, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Alphonse Pecoraro, MD (he/him) is a Surgeon in Rockledge, FL with over 18 years of experience. What is your opinion of Dr. Alphonse Pecoraro, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Alphonse Pecoraro, MD has received over $6,947 which includes payments from the following companies:
$5,248.08 from Intuitive Surgical, Inc.
$361.57 from Organogenesis Inc.
$210.16 from Smith & Nephew, Inc.
$195.93 from Genentech USA, Inc.
$157.51 from Bayer HealthCare Pharmaceuticals Inc.
$142.26 from The Medicines Company
$117.10 from Osiris Therapeutics Inc.
$84.18 from Cianna Medical, Inc
$83.33 from CONMED Corporation
$77.02 from Mallinckrodt LLC
$37.41 from TEI Biosciences Inc
$28.13 from Ethicon US, LLC
$27.27 from Aesculap, Inc.
$21.63 from Allergan Inc.
$21.37 from ACell, Inc.
$21.19 from Baxter Healthcare
$19.47 from Biocompatibles, Inc.
$19.26 from Celgene Corporation
$17.32 from Bard Peripheral Vascular, Inc.
$16.41 from KCI USA, Inc
Payments received by Dr. Alphonse Pecoraro, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!